98 related articles for article (PubMed ID: 27133594)
1. Piperidine derivatives as nonprostanoid IP receptor agonists 2.
Hayashi R; Ito H; Ishigaki T; Morita Y; Miyamoto M; Isogaya M
Bioorg Med Chem Lett; 2016 Jun; 26(12):2886-2889. PubMed ID: 27133594
[TBL] [Abstract][Full Text] [Related]
2. Piperidine derivatives as nonprostanoid IP receptor agonists.
Hayashi R; Sakagami H; Koiwa M; Ito H; Miyamoto M; Isogaya M
Bioorg Med Chem Lett; 2016 May; 26(9):2360-4. PubMed ID: 26996371
[TBL] [Abstract][Full Text] [Related]
3. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.
Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS; Zavoico GB
J Med Chem; 1993 Nov; 36(24):3871-83. PubMed ID: 8254619
[TBL] [Abstract][Full Text] [Related]
4. Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
Meanwell NA; Romine JL; Rosenfeld MJ; Martin SW; Trehan AK; Wright JJ; Malley MF; Gougoutas JZ; Brassard CL; Buchanan JO
J Med Chem; 1993 Nov; 36(24):3884-903. PubMed ID: 7504734
[TBL] [Abstract][Full Text] [Related]
5. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
[TBL] [Abstract][Full Text] [Related]
6. Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.
Asaki T; Kuwano K; Morrison K; Gatfield J; Hamamoto T; Clozel M
J Med Chem; 2015 Sep; 58(18):7128-37. PubMed ID: 26291199
[TBL] [Abstract][Full Text] [Related]
7. Nonprostanoid prostacyclin mimetics. 3. Structural variations of the diphenyl heterocycle moiety.
Meanwell NA; Rosenfeld MJ; Trehan AK; Romine JL; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M
J Med Chem; 1992 Sep; 35(19):3498-512. PubMed ID: 1404231
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists.
Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K; Niwa T
Bioorg Med Chem Lett; 2007 Dec; 17(23):6588-92. PubMed ID: 17920266
[TBL] [Abstract][Full Text] [Related]
9. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
[TBL] [Abstract][Full Text] [Related]
10. GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure.
Hayashi Y; Katada J; Harada T; Tachiki A; Iijima K; Takiguchi Y; Muramatsu M; Miyazaki H; Asari T; Okazaki T; Sato Y; Yasuda E; Yano M; Uno I; Ojima I
J Med Chem; 1998 Jun; 41(13):2345-60. PubMed ID: 9632368
[TBL] [Abstract][Full Text] [Related]
11. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonists.
Ishikawa M; Kubota D; Yamamoto M; Kuroda C; Iguchi M; Koyanagi A; Murakami S; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2109-30. PubMed ID: 16309912
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists.
Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K
Bioorg Med Chem; 2007 Nov; 15(21):6692-704. PubMed ID: 17764960
[TBL] [Abstract][Full Text] [Related]
13. Nonprostanoid prostacyclin mimetics. 2. 4,5-Diphenyloxazole derivatives.
Meanwell NA; Rosenfeld MJ; Trehan AK; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Zavoico GB
J Med Chem; 1992 Sep; 35(19):3483-97. PubMed ID: 1404230
[TBL] [Abstract][Full Text] [Related]
14. Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: orally active prostacyclin mimetics. Part 3.
Hattori K; Tanaka A; Okitsu O; Tabuchi S; Taniguchi K; Nishio M; Koyama S; Higaki M; Seki J; Sakane K
Bioorg Med Chem Lett; 2005 Jun; 15(12):3091-5. PubMed ID: 15914004
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.
Kubota D; Ishikawa M; Yamamoto M; Murakami S; Hachisu M; Katano K; Ajito K
Bioorg Med Chem; 2006 Apr; 14(7):2089-108. PubMed ID: 16309911
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonist.
Nakamura A; Yamada T; Asaki T
Bioorg Med Chem; 2007 Dec; 15(24):7720-5. PubMed ID: 17881233
[TBL] [Abstract][Full Text] [Related]
17. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
18. Investigation of piperidine derivatives in ex vivo models of pain and platelet aggregation.
Saify ZS; Rasheed H; Mushtaq N; Nisa M; Haider S; Naz A; Azhar KF; Miana GA
Arch Pharm Res; 2012 Nov; 35(11):1953-9. PubMed ID: 23212637
[TBL] [Abstract][Full Text] [Related]
19. A novel pyridazinone derivative as a nonprostanoid PGI2 agonist.
Tsubaki K; Taniguchi K; Tabuchi S; Okitsu O; Hattori K; Seki J; Sakane K; Tanaka H
Bioorg Med Chem Lett; 2000 Dec; 10(24):2787-90. PubMed ID: 11133092
[TBL] [Abstract][Full Text] [Related]
20. Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids.
de Candia M; Summo L; Carrieri A; Altomare C; Nardecchia A; Cellamare S; Carotti A
Bioorg Med Chem; 2003 Apr; 11(7):1439-50. PubMed ID: 12628670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
